
REDMILE GROUP, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ADCT | 15.67M | $55.30M |
![]() | FATE | 12.87M | $12.65M |
![]() | ANNX | 10.05M | $50.45M |
![]() | ABSI | 8.25M | $28.80M |
![]() | NRIX | 8.09M | $153.54M |
![]() | IMNM | 5.72M | $122.83M |
![]() | STTK | 5.54M | $20.22M |
![]() | SRRK | 5.22M | $229.98M |
![]() | RGNX | 4.37M | $62.91M |
![]() | STOK | 4.03M | $128.04M |
![]() | ALXO | 3.26M | $3.69M |
![]() | NUVB | 3.16M | $28.34M |
![]() | IVVD | 2.68M | $6.62M |
![]() | SLN | 2.16M | $13.16M |
![]() | SLDB | 1.86M | $10.49M |
![]() | PLRX | 1.62M | $1.97M |
![]() | RPTX | 1.59M | $4.12M |
![]() | NGNE | 1.46M | $30.07M |
![]() | COGT | 1.44M | $51.07M |
![]() | BEAM | 1.29M | $35.64M |

ADC Therapeutics S.A.
ADCT
Shares Held
15.67M
Value
$55.30M

Fate Therapeutics, Inc.
FATE
Shares Held
12.87M
Value
$12.65M

Annexon, Inc.
ANNX
Shares Held
10.05M
Value
$50.45M

Absci Corporation
ABSI
Shares Held
8.25M
Value
$28.80M

Nurix Therapeutics, Inc.
NRIX
Shares Held
8.09M
Value
$153.54M

Immunome, Inc.
IMNM
Shares Held
5.72M
Value
$122.83M

Shattuck Labs, Inc.
STTK
Shares Held
5.54M
Value
$20.22M

Scholar Rock Holding Corporation
SRRK
Shares Held
5.22M
Value
$229.98M

REGENXBIO Inc.
RGNX
Shares Held
4.37M
Value
$62.91M

Stoke Therapeutics, Inc.
STOK
Shares Held
4.03M
Value
$128.04M

ALX Oncology Holdings Inc.
ALXO
Shares Held
3.26M
Value
$3.69M

Nuvation Bio Inc.
NUVB
Shares Held
3.16M
Value
$28.34M

Invivyd, Inc.
IVVD
Shares Held
2.68M
Value
$6.62M

Silence Therapeutics plc
SLN
Shares Held
2.16M
Value
$13.16M

Solid Biosciences Inc.
SLDB
Shares Held
1.86M
Value
$10.49M

Pliant Therapeutics, Inc.
PLRX
Shares Held
1.62M
Value
$1.97M

Repare Therapeutics Inc.
RPTX
Shares Held
1.59M
Value
$4.12M

Neurogene Inc.
NGNE
Shares Held
1.46M
Value
$30.07M

Cogent Biosciences, Inc.
COGT
Shares Held
1.44M
Value
$51.07M

Beam Therapeutics Inc.
BEAM
Shares Held
1.29M
Value
$35.64M
